Aclaris Therapeutics, Inc. ACRS
$4.33
▼ -1.14% 24H
About
Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases. It operates through two segments: Therapeutics, which identifies and advances innovative therapies to meet unmet needs in conditions such as atopic dermatitis, asthma, an…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees69
TickerACRS
Statistics
Market Cap$605.4M
Revenue (TTM)$7.8M
Net Income-$64.9M
Net Margin-829.6%
EPS$-0.53
P/E-8.26
P/S72.94
P/B4.25
EV/EBITDA-6.46
ROE-48.4%
Dividend Yield—
Price$4.33
Data: Twelve Data · Revenue = mcap / P/S